• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

GKKKKSVQWCA details
Primary information
ID antitb_1170,
Name24709266
N-Terminal modificationhLFcin1-11 all K
C-Terminal ModificationGKKKKSVQWCA
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature11
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium avium
In Vitro/ In vivoMycobacterium avium strain 2447 smooth transparent variant (SmT)
Cell LineIC50 = 39.1 ± 6.9
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityNone
In vivo ModelNA
Lethal DoseNA
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyPermeabilization of peptide causes significant changes both in the surface and in the ultrastructural organization of the mycobacterial cells.
Other activitiesCell envelope
PMIDNone
Year of PublicationNone
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1899,
Name24709266
N-Terminal modificationHuman lactoferricin 1-11
C-Terminal ModificationGKKKKSVQWCA
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature11
SourceL
OriginCationic
SpeciesNatural
StrainDerived from human lactoferricin protein
Inhibition ConcentrationMycobacterium avium
In Vitro/ In vivoMycobacterium avium
Cell LineMycobacterium avium 2447 smT
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 50% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),